Showing results (2271-2280 of 2,283) with videos related to

Sort By:
Pageof 229
Med (New York, N.Y.)|April 7, 2026
Comparative efficacy of phase 2-3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysisTsubasa Tsutsumi, Nicole Shu Ying Tang, Cheng Han Ng, et al.
Plant Physiology|June 23, 2004
Genome-wide ORFeome cloning and analysis of Arabidopsis transcription factor genesWei Gong, Yun-Ping Shen, Li-Geng Ma, et al.
Circulation|February 15, 2019
BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary HypertensionQiujun Yu, Yi-Yin Tai, Ying Tang, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Unique nasal cell states induced by common pediatric respiratory virusesJaclyn M L Walsh, Lillian J Juttukonda, Ying Tang, et al.
Nature Immunology|January 20, 2025
Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2Jaclyn M L Walsh, Vincent N Miao, Anna H Owings, et al.
Translational Neurodegeneration|February 16, 2021
Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in ChinaLi Cao, Xiaojun Huang, Ning Wang, et al.
Med (New York, N.Y.)|January 19, 2025
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trialHuayi Li, Yu Xu, Xiaofei Jiao, et al.
Critical Care (London, England)|July 29, 2025
Use of extracorporeal membrane oxygenation in adult trauma patients with refractory acute cardiopulmonary failure: guideline from the Chinese society of extracorporeal life support 2025Hua Wang, Zhongran Cen, Xingxing Liu, et al.
Science Translational Medicine|January 10, 2024
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertensionYi-Yin Tai, Qiujun Yu, Ying Tang, et al.
Lancet (London, England)|October 19, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaXiaohua Wu, Yang Sun, Hongying Yang, et al.
Pageof 229